Bar-Ilan University and Sheba Medical Center establish joint research institute for biotech innovation with $120 million investment
Business Announcement
Updates every hour. Last Updated: 29-Dec-2025 00:11 ET (29-Dec-2025 05:11 GMT/UTC)
Bar-Ilan University and Sheba Medical Center are establishing a $120 million joint biotech research institute at Sheba’s new Health Tech Valley in Ramat Gan. Modeled after the U.S. NIH, the institute will bridge academia, healthcare, and industry to accelerate the translation of lab discoveries into clinical treatments. Research will focus on cancer, 3D organ printing, AI-driven medical data, robotics, genetic engineering, and microbiome science, with the aim of fast-tracking personalized medicine, new drugs, and advanced devices.
Leaders from both institutions stressed the institute’s role in positioning Israel as a global hub for biotech innovation, a magnet for billions in investment, and a powerful growth engine for the economy.
Prof. Yitshak Kreiss, Director General of Sheba Medical Center: “The healthcare system is a powerful growth engine for the economy and industry."
Prof. Arie Zaban, President of Bar-Ilan University: "Biotechnology has become a focus of investment, drawing billions of shekels annually”.
Altuna Akalin and his team at the Max Delbrück Center have developed a new tool to more precisely guide cancer treatment. Described in a paper published in “Nature Communications,” the tool, called Flexynesis, uses deep neural networks and evaluates multi modal data.
Recently, a review titled "Circulating tumor cell-derived organoids: current progress, applications, and future" was published in MedComm - Future Medicine. The article systematically summarises the research progress, application scenarios, and future challenges of organoids derived from circulating tumor cells (CTCs). This study comprehensively reviews the biological characteristics of CTCs, strategies for their isolation and enrichment, optimisation techniques for in vitro culture systems, and their significance in basic research, translational medicine, and clinical applications.